Dopamine increases CD14+CD16+ monocyte migration and adhesion in the context of substance abuse and HIV neuropathogenesis

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Coley, Jacqueline S ^a   Calderon, Tina M ^a   Gaskill, Peter J ^a   Eugenin, Eliseo A ^b   Berman, Joan W ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; ANTIRETROVIRUS AGENT; CD14 ANTIGEN; CD16 ANTIGEN; CELL SURFACE PROTEIN; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; FC RECEPTOR;

ARTICLE; BLOOD BRAIN BARRIER; BRAIN REGION; CELL ADHESION; CELL CULTURE; CELL ISOLATION; CELL MIGRATION; CELL MOTILITY; CENTRAL NERVOUS SYSTEM; CHEMOKINESIS; COMORBIDITY; CONTROLLED STUDY; FLOW CYTOMETRY; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONOCYTE; NERVOUS SYSTEM INFLAMMATION; NEUROPATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBSTANCE ABUSE; VIRUS ENTRY; BRAIN; CELL MOTION; COMPLICATION; CYTOLOGY; DRUG DEPENDENCE; ISOLATION AND PURIFICATION; METABOLISM; PATHOLOGY; VIROLOGY;

ANTIGENS, CD14; BRAIN; CELL ADHESION; CELL MOVEMENT; CELLS, CULTURED; DOPAMINE; HIV; HIV INFECTIONS; HUMANS; MONOCYTES; RECEPTORS, IGG; SUBSTANCE-RELATED DISORDERS;

EID: 84922367908     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0117450     Document Type: Article

References (79)

1. Davis LE, Hjelle BL, Miller VE, Palmer DL, Llewellyn AL, et al. (1992) Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology 42: 1736-1739. PMID: 1513462
2. Valcour V, Chalermchai T, Sailasuta N, Marovich M, Lerdlum S, et al. (2012) Central Nervous System Viral Invasion and Inflammation During Acute HIV Infection. J Infect Dis 206: 275-282. doi: 10.1093/ infdis/jis326 PMID: 22551810
3. Heaton RK, Clifford DB, Franklin DR, Woods SP, Ake C, et al. (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy. Neurology 75: 2087-2096. doi: 10.1212/ WNL.0b013e318200d727 PMID: 21135382
4. Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, et al. (2011) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol 17: 3-16. doi: 10.1007/s13365-010-0006-1 PMID: 21174240
5. Simioni S, Cavassini M, Annoni JM, Rimbault Abraham A, Bourquin I, et al. (2010) Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS 24: 1243-1250 1210.1097/ QAD.1240b1013e3283354a3283357b. doi: 10.1097/QAD.0b013e3283354a7b PMID: 19996937
6. Peluso R, Haase A, Stowring L, Edwards M, Ventura P (1985) A Trojan Horse mechanism for the spread of visna virus in monocytes. Virology 147: 231-236. PMID: 2998068
7. Pulliam L, Gascon R, Stubblebine M, McGuire D, McGrath MS (1997) Unique monocyte subset in patients with AIDS dementia. Lancet 349: 692-695. PMID: 9078201
8. Cinque P, Vago L, Mengozzi M, Torri V, Ceresa D, et al. (1998) Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication. AIDS 12: 1327-1332. PMID: 9708412
9. Peng H, Erdmann N, Whitney N, Dou H, Gorantla S, et al. (2006) HIV-1-infected and/or immune activated macrophages regulate astrocyte SDF-1 production through IL-1β. Glia 54: 619-629. PMID: 16944452
10. Bleul CC, Fuhlbrigge RC, Casasnovas JM, Aiuti A, Springer TA (1996) A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med 184: 1101-1109. PMID: 9064327
11. Eugenin EA, Osiecki K, Lopez L, Goldstein H, Calderon TM, et al. (2006) CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS. J Neurosci 26: 1098-1106. PMID: 16436595
12. Weiss JM, Downie SA, Lyman WD, Berman JW (1998) Astrocyte-Derived Monocyte-Chemoattractant Protein-1 Directs the Transmigration of Leukocytes Across a Model of the Human Blood-Brain Barrier. J Immunol 161: 6896-6903. PMID: 9862722
13. Williams D, Veenstra M, Gaskill PJ, Morgello S, Calderon TM, et al. (2014) Monocytes Mediate HIV Neuropathogenesis: Mechanisms that Contribute to HIV Associated Neurocognitive Disorders. Curr HIV Res 12: 85-96. PMID: 24862333
14. Wu DT, Woodman SE, Weiss JM, McManus CM, D'Aversa TG, et al. (2000) Mechanisms of leukocyte trafficking into the CNS. J Neurovirol 6: S82-S85. PMID: 10871769
15. Shiramizu B, Paul R, Williams A, Shikuma C, Watters M, et al. (2007) HIV Proviral DNA Associated With Decreased Neuropsychological Function. J Neuropsychiatry Clin Neurosci 19: 157-163. PMID: 17431062
16. Valcour VG, Shiramizu BT, Shikuma CM (2010) HIV DNA in circulating monocytes as a mechanism to dementia and other HIV complications. J Leukoc Biol 87: 621-626. doi: 10.1189/jlb.0809571 PMID: 20130221
17. Tacke F, Randolph G (2006) Migratory fate and differentiation of blood monocyte subsets. Immunobiology 211: 609-618. PMID: 16920499
18. Ziegler-Heitbrock HWL, Fingerle G, Ströbel M, Schraut W, Stelter F, et al. (1993) The novel subset of CD14+/CD16+ blood monocytes exhibits features of tissue macrophages. Eur J Immunol 23: 2053-2058. PMID: 7690321
19. Nockher WA (1994) Increased soluble CD14 serum levels and altered CD14 expression of peripheral blood monocytes in HIV-infected patients. Clin Exp Immunol 98: 369-374. PMID: 7527738
20. Thieblemont N, Weiss L, Sadeghi HM, Estcourt C, Haeffner-Cavaillon N (1995) CD14lowCD16high: a cytokine-producing monocyte subset which expands during human immunodeficiency virus infection. Eur J Immunol 25: 3418-3424. PMID: 8566032
21. Williams DW, Calderon TM, Lopez L, Carvallo-Torres L, Gaskill PJ, et al. (2013) Mechanisms of HIV Entry into the CNS: Increased Sensitivity of HIV Infected CD14+CD16+ Monocytes to CCL2 and Key Roles of CCR2, JAM-A, and ALCAM in Diapedesis. PLoS ONE 8: e69270. doi: 10.1371/journal.pone. 0069270 PMID: 23922698
22. Ancuta P, Kunstman K, Autissier P, Zaman T, Stone D, et al. (2006) CD16+ monocytes exposed to HIV promote highly efficient viral replication upon differentiation into macrophages and interaction with T cells. Virology 344: 267-276. PMID: 16305804
23. Buckner CM, Calderon TM, Willams DW, Belbin TJ, Berman JW (2011) Characterization of monocyte maturation/differentiation that facilitates their transmigration across the blood-brain barrier and infection by HIV: Implications for NeuroAIDS. Cell Immunol 267: 109-123. doi: 10.1016/j.cellimm.2010.12.004 PMID: 21292246
24. Ellery PJ, Tippett E, Chiu YL, Paukovics G, Cameron PU, et al. (2007) The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo. J Immunol 178: 6581-6589. PMID: 17475889
25. Fischer-Smith T (2008) Monocyte/macrophage trafficking in acquired immunodeficiency syndrome encephalitis: Lessons from human and nonhuman primate studies. J Neurovirol 14: 318-326. doi: 10.1080/13550280802132857 PMID: 18780233
26. Fischer-Smith T, Croul S, Adeniyi A, Rybicka K, Morgello S, et al. (2004) Macrophage/Microglial Accumulation and Proliferating Cell Nuclear Antigen Expression in the Central Nervous System in Human Immunodeficiency Virus Encephalopathy. Am J Pathol 164: 2089-2099. PMID: 15161643
27. Fischer-Smith T, Croul S, Sverstiuk AE, Capini C, L'Heureux D, et al. (2001) CNS invasion by CD14 +/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection. J Neurovirol 7: 528-541.
28. Kim W-K, Alvarez X, Fisher J, Bronfin B, Westmoreland S, et al. (2006) CD163 Identifies Perivascular Macrophages in Normal and Viral Encephalitic Brains and Potential Precursors to Perivascular Macrophages in Blood. Am J Pathol 168: 822-834. PMID: 16507898
29. Williams KC, Corey S, Westmoreland SV, Pauley D, Knight H, et al. (2001) Perivascular Macrophages Are the Primary Cell Type Productively Infected by Simian Immunodeficiency Virus in the Brains of Macaques: Implications for the Neuropathogenesis of AIDS. J Exp Med 193: 905-916. PMID: 11304551
30. Beyrer C, Wirtz AL, Baral S, Peryskina A, Sifakis F (2010) Epidemiologic links between drug use and HIV epidemics: an international perspective. J Acquir Immune Defic Syndr 55 Suppl 1: S10-16. doi: 10.1097/QAI.0b013e3181f9c0c9 PMID: 21045593
31. Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, et al. (2008) Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet 372: 1733-1745. doi: 10.1016/S0140-6736(08)61311-2 PMID: 18817968
32. Carboni E, Imperato A, Perezzani L, Di Chiara G (1989) Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats. Neuroscience 28: 653-661. PMID: 2710338
33. Di Chiara G, Bassareo V (2007) Reward system and addiction: what dopamine does and doesn't do. Curr Opin Pharmacol 7: 69-76. PMID: 17174602
34. Di Chiara G, Imperato A (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A 85: 5274-5278. PMID: 2899326
35. Iversen SD, Iversen LL (2007) Dopamine: 50 years in perspective. Trends Neurosci 30: 188-193. PMID: 17368565
36. Parsons LH, Justice JB Jr. (1992) Extracellular concentration and in vivo recovery of dopamine in the nucleus accumbens using microdialysis. J Neurochem 58: 212-218. PMID: 1727431
37. Pontieri FE, Tanda G, Di Chiara G (1995) Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens. Proc Natl Acad Sci U S A 92: 12304-12308. PMID: 8618890
38. Bell JE, Arango JC, Robertson R, Brettle RP, Leen C, et al. (2002) HIV and drug misuse in the Edinburgh cohort. J Acquir Immune Defic Syndr 31 Suppl 2: S35-42. PMID: 12394781
39. Gray F, Lescs MC, Keohane C, Paraire F, Marc B, et al. (1992) Early brain changes in HIV infection: neuropathological study of 11 HIV seropositive, non-AIDS cases. J Neuropathol Exp Neurol 51: 177-185. PMID: 1538241
40. Langford D, Adame A, Grigorian A, Grant I, McCutchan JA, et al. (2003) Patterns of selective neuronal damage in methamphetamine-user AIDS patients. J Acquir Immune Defic Syndr 34: 467-474. PMID: 14657756
41. Meade CS, Conn NA, Skalski LM, Safren SA (2011) Neurocognitive impairment and medication adherence in HIV patients with and without cocaine dependence. J Behav Med 34: 128-138. doi: 10.1007/ s10865-010-9293-5 PMID: 20857187
42. Weber E, Morgan E, Iudicello J, Blackstone K, Grant I, et al. (2013) Substance use is a risk factor for neurocognitive deficits and neuropsychiatric distress in acute and early HIV infection. J Neurovirol 19: 65-74. doi: 10.1007/s13365-012-0141-y PMID: 23250704
43. Czub S, Czub M, Koutsilieri E, Sopper S, Villinger F, et al. (2004) Modulation of simian immunodeficiency virus neuropathology by dopaminergic drugs. Acta Neuropathol 107: 216-226. PMID: 14712399
44. Czub S, Koutsilieri E, Sopper S, Czub M, Stahl-Hennig C, et al. (2001) Enhancement of central nervous system pathology in early simian immunodeficiency virus infection by dopaminergic drugs. Acta Neuropathol 101: 85-91. PMID: 11271377
45. Beaulieu JM, Gainetdinov RR (2011) The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev 63: 182-217. doi: 10.1124/pr.110.002642 PMID: 21303898
46. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG (1998) Dopamine receptors: from structure to function. Physiol Rev 78: 189-225. PMID: 9457173
47. Neve KA, Seamans JK, Trantham-Davidson H (2004) Dopamine receptor signaling. J Recept Signal Transduct Res 24: 165-205. PMID: 15521361
48. Gaskill PJ, Calderon TM, Luers AJ, Eugenin EA, Javitch JA, et al. (2009) Human Immunodeficiency Virus (HIV) Infection of Human Macrophages Is Increased by Dopamine: A Bridge between HIV-Associated Neurologic Disorders and Drug Abuse. Am J Pathol 175: 1148-1159. doi: 10.2353/ajpath.2009. 081067 PMID: 19661443
49. Duport S, Robert F, Muller D, Grau G, Parisi L, et al. (1998) An in vitro blood-brain barrier model: Cocultures between endothelial cells and organotypic brain slice cultures. Proc Natl Acad Sci U S A 95: 1840-1845. PMID: 9465104
50. Cragg SJ, Rice ME (2004) DAncing past the DAT at a DA synapse. Trends Neurosci 27: 270-277. PMID: 15111009
51. Garris PA, Ciolkowski EL, Pastore P, Wightman RM (1994) Efflux of dopamine from the synaptic cleft in the nucleus accumbens of the rat brain. J Neurosci 14: 6084-6093. PMID: 7931564
52. McKenna F, McLaughlin PJ, Lewis BJ, Sibbring GC, Cummerson JA, et al. (2002) Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: a flow cytometric study. J Neuroimmunol 132: 34-40. PMID: 12417431
53. Watanabe Y, Nakayama T, Nagakubo D, Hieshima K, Jin Z, et al. (2006) Dopamine selectively induces migration and homing of naive CD8+ T cells via dopamine receptor D3. J Immunol 176: 848-856. PMID: 16393968
54. Fischer-Smith T, Tedaldi EM, Rappaport J (2008) CD163/CD16 Coexpression by Circulating Monocytes/ Macrophages in HIV: Potential Biomarkers for HIV Infection and AIDS Progression. AIDS Res Hum Retroviruses 24: 417-421. doi: 10.1089/aid.2007.0193 PMID: 18373432
55. Hanami K, Nakano K, Saito K, Okada Y, Yamaoka K, et al. (2013) Dopamine D2-like receptor signaling suppresses human osteoclastogenesis. Bone 56: 1-8. doi: 10.1016/j.bone.2013.04.019 PMID: 23631878
56. Kustrimovic N, Rasini E, Legnaro M, Marino F, Cosentino M (2014) Expression of dopaminergic receptors on human CD4+ T lymphocytes: flow cytometric analysis of naive and memory subsets and relevance for the neuroimmunology of neurodegenerative disease. J Neuroimmune Pharmacol 9: 302-312. doi: 10.1007/s11481-014-9541-5 PMID: 24682738
57. Huang C, Jacobson K, Schaller MD (2004) MAP kinases and cell migration. J Cell Sci 117: 4619-4628. PMID: 15371522
58. Chen J, Rusnak M, Lombroso PJ, Sidhu A (2009) Dopamine promotes striatal neuronal apoptotic death via ERK signaling cascades. Eur J Neurosci 29: 287-306. doi: 10.1111/j.1460-9568.2008. 06590.x PMID: 19200235
59. Fiorentini C, Mattanza C, Collo G, Savoia P, Spano P, et al. (2011) The tyrosine phosphatase Shp-2 interacts with the dopamine D(1) receptor and triggers D(1) -mediated Erk signaling in striatal neurons. J Neurochem 117: 253-263. doi: 10.1111/j.1471-4159.2011.07196.x PMID: 21272002
60. Farber K, Pannasch U, Kettenmann H (2005) Dopamine and noradrenaline control distinct functions in rodent microglial cells. Mol Cell Neurosci 29: 128-138. PMID: 15866053
61. Anthony IC, Ramage SN, Carnie FW, Simmonds P, Bell JE (2005) Influence of HAART on HIV-related CNS disease and neuroinflammation. J Neuropathol Exp Neurol 64: 529-536. PMID: 15977645
62. Harezlak J, Buchthal S, Taylor M, Schifitto G, Zhong J, et al. (2011) Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment. AIDS 25: 625-633. doi: 10.1097/QAD.0b013e3283427da7 PMID: 21297425
63. Xi ZX, Kleitz HK, Deng X, Ladenheim B, Peng XQ, et al. (2009) A single high dose of methamphetamine increases cocaine self-administration by depletion of striatal dopamine in rats. Neuroscience 161: 392-402. doi: 10.1016/j.neuroscience.2009.03.060 PMID: 19336247
64. Zachek MK, Takmakov P, Park J, Wightman RM, McCarty GS (2010) Simultaneous monitoring of dopamine concentration at spatially different brain locations in vivo. Biosens Bioelectron 25: 1179-1185. doi: 10.1016/j.bios.2009.10.008 PMID: 19896822
65. Kamat A, Lyons JL, Misra V, Uno H, Morgello S, et al. (2012) Monocyte Activation Markers in Cerebrospinal Fluid Associated With Impaired Neurocognitive Testing in Advanced HIV Infection. J Acquir Immune Defic Syndr 60: 234-243 doi: 10.1097/QAI.0b013e318256f3bc PMID: 22569268
66. Kraft-Terry SD, Stothert AR, Buch S, Gendelman HE (2010) HIV-1 neuroimmunity in the era of antiretroviral therapy. Neurobiol Dis 37: 542-548. doi: 10.1016/j.nbd.2009.12.015 PMID: 20044002
67. Abbott NJ, Ronnback L, Hansson E (2006) Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7: 41-53. PMID: 16371949
68. Gaskill P, Carvallo L, Eugenin E, Berman J (2012) Characterization and function of the human macrophage dopaminergic system: implications for CNS disease and drug abuse. J Neuroinflammation 9:203. doi: 10.1186/1742-2094-9-203 PMID: 22901451
69. Ortega E, Garcia JJ, De la Fuente M (2000) Modulation of adherence and chemotaxis of macrophages by norepinephrine. Influence of ageing. Mol Cell Biochem 203: 113-117. PMID: 10724339
70. Straub RH, Mayer M, Kreutz M, Leeb S, Scholmerich J, et al. (2000) Neurotransmitters of the sympathetic nerve terminal are powerful chemoattractants for monocytes. J Leukoc Biol 67: 553-558. PMID: 10770289
71. Nelson PK, Mathers BM, Cowie B, Hagan H, Des Jarlais D, et al. (2011) Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet 378: 571-583. doi: 10.1016/S0140-6736(11)61097-0 PMID: 21802134
72. Rodriguez-Munoz Y, Martin-Vilchez S, Lopez-Rodriguez R, Hernandez-Bartolome A, Trapero-Marugan M, et al. (2011) Peripheral blood monocyte subsets predict antiviral response in chronic hepatitis C. Aliment Pharmacol Ther 34: 960-971. doi: 10.1111/j.1365-2036.2011.04807.x PMID: 21848603
73. Zhang J-Y, Zou Z-S, Huang A, Zhang Z, Fu J-L, et al. (2011) Hyper-Activated Pro-Inflammatory CD16+ Monocytes Correlate with the Severity of Liver Injury and Fibrosis in Patients with Chronic Hepatitis B. PLoS ONE 6: e17484. doi: 10.1371/journal.pone.0017484 PMID: 21390263
74. Forton DM, Thomas HC, Murphy CA, Allsop JM, Foster GR, et al. (2002) Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology 35: 433-439. PMID: 11826420
75. Grover VP, Pavese N, Koh SB, Wylezinska M, Saxby BK, et al. (2012) Cerebral microglial activation in patients with hepatitis C: in vivo evidence of neuroinflammation. J Viral Hepat 19: e89-96. doi: 10.1111/j.1365-2893.2011.01510.x PMID: 22239531
76. Hilsabeck RC, Hassanein TI, Carlson MD, Ziegler EA, PerryW(2003) Cognitive functioning and psychiatric symptomatology in patients with chronic hepatitis C. J Int Neuropsychol Soc 9: 847-854. PMID: 14632243
77. Weissenborn K, Krause J, Bokemeyer M, Hecker H, Schuler A, et al. (2004) Hepatitis C virus infection affects the brain-evidence from psychometric studies and magnetic resonance spectroscopy. J Hepatol 41: 845-851. PMID: 15519659
78. Wilkinson J, Radkowski M, Eschbacher JM, Laskus T (2010) Activation of brain macrophages/microglia cells in hepatitis C infection. Gut 59: 1394-1400. doi: 10.1136/gut.2009.199356 PMID: 20675697
79. Cherner M, Letendre S, Heaton RK, Durelle J, Marquie-Beck J, et al. (2005) Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine. Neurology 64: 1343-1347. PMID: 15851720